Peptide-based LDH5 inhibitors enter cancer cells and impair proliferation. (2022)
Attributed to:
From Peptides to Mimetics: Towards Smaller More Stable Drug-like Protein-protein Interaction Inhibitors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00018-022-04633-3
PubMed Identifier: 36436181
Publication URI: http://europepmc.org/abstract/MED/36436181
Type: Journal Article/Review
Volume: 79
Parent Publication: Cellular and molecular life sciences : CMLS
Issue: 12
ISSN: 1420-682X